Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pancreatic Neoplasms 8Multiple Myeloma 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Prostatic Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Inflammation 2Frailty 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Ventilator-Induced Lung Injury 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Postoperative Complications 1Pancreatic Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Mucositis 1

Interventions

Temozolomide 154Bevacizumab 88Radiotherapy 75Radiation 23Magnetic Resonance Spectroscopy 23Lomustine 18Irinotecan 18pembrolizumab 17Surgical Procedures, Operative 16Carmustine 16Erlotinib Hydrochloride 12Nivolumab 11Specimen Handling 10Aminolevulinic Acid 10sargramostim 9Thalidomide 9Chemotherapy, Adjuvant 9Carboplatin 9Drug Therapy 8Immunoglobulin G 7Filgrastim 7Etoposide 7Disulfides 7Cilengitide 7Sunitinib 6Sorafenib 6O(6)-benzylguanine 6Cyclophosphamide 6antineoplaston AS 2-1 5antineoplaston A10 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Glioblastoma × Ascorbic Acid × Clear all
NCT02344355 2025-12-12

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

University of Iowa

Phase 2 Active not recruiting
90 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡